Czechia now has its own "orphan drugs" bill

13. 10. 2021

Recently, the Chamber of Deputies approved the Amendment no. 48 to Public Health Insurance Law. The new legislation, valid as of 1st January 2022, addresses the topic of "orphan drugs" and HTA processes, which are usually highly relevant for patients with rare diseases such as HAE. This new bill sets special conditions for reimbursement as part of the national public health insurance system and it enables the involvement of patient organizations in the approval process.

HAE Junior patient organization closely monitors these legislative changes and regularly provides updates for the patient community (and not only) via HAE Junior Newsletter.


Contact:

HAE Junior non-profit organisation
Wichterlova 2372/8, 
Prague 8, 182 00
Organisation ID 08749787

info@haejunior.cz
704 007 717

Contact for journalists:
media@haejunior.cz

Media kit download
 

Contact us

    Will you support us?

    Support us - HAE Junior cz

    You can send your financial donation also to our bank account 2001782429/2010.

    Partners:

    TakedaKalvistaPharming
    Avastlogo PBA
    SmartGoal

    National & international affiliations:

    Logo EurodisČeská asociace pro vzácná onemocněníPacientský hubAIP

    Media partners

    Adalo Solutions s.r.o. ©  2020 - 2021 | All rights reserved